Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade

Core Viewpoint - Stoke Therapeutics, Inc. (STOK) has shown a significant price increase of 16.4% over the past four weeks, with a mean price target of $22.14 indicating a potential upside of 66.8$13.27 [1] Price Target Analysis - The average price target consists of seven estimates ranging from a low of $14 to a high of$35, with a standard deviation of $7.38, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 5.5% increase, while the highest suggests a 163.8% upside, highlighting the range of potential outcomes [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about STOK's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][9] - The Zacks Consensus Estimate for the current year has risen by 3.1% over the past month, with four estimates increasing and no negative revisions [10] Zacks Rank and Investment Potential - STOK holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [11]